Table 1.

Relation of MMP12 Expression With Overall Survival (OS) and Disease-specific Survival (DSS) of Cancer Patients.

Cancer (sample)	OS HR a	P-value	Cancer (sample)	DSS HR	P-value
ACC (41)	1.555	.002	ACC (39)	6.396	<.001
BLCA (416)	.975	.455	BLCA (401)	.972	.496
BRCA (1143)	.879	.031	BRCA (1115)	.926	.324
CESC (273)	1.072	.253	CESC (272)	1.062	.380
CHOL (40)	.988	.949	CHOL (38)	1.045	.809
COAD (317)	.920	.184	COAD (302)	.920	.339
DLBC (44)	1.035	.865	DLBC (44)	1.210	.488
ESCA (188)	1.099	.119	ESCA (185)	1.217	.007
GBM (114)	.888	.373	GBM (106)	.895	.429
HNSCC (554)	.974	.437	HNSCC (526)	.959	.347
KICH (77)	2.440	.055	KICH (77)	3.341	.017
KIRC (500)	1.282	<.001	KIRC (486)	1.303	<.001
KIRP (240)	1.007	.979	KIRP (238)	1.147	.576
LGG (205)	1.118	.721	LGG (201)	1.175	.606
LIHC (326)	1.121	.086	LIHC (317)	1.078	.390
LUAD (549)	1.042	.230	LUAD (515)	1.005	.913
LUSC (515)	1.000	.989	LUSC (457)	.957	.396
MESO (67)	1.001	.993	MESO (49)	.913	.528
OV (382)	.947	.337	OV (354)	.946	.369
PAAD (176)	1.146	.034	PAAD (170)	1.159	.037
PCPG (93)	1.408	.425	PCPG (93)	1.240	.718
PRAD (518)	.615	.410	PRAD (516)	.961	.951
READ (101)	.939	.664	READ (95)	.885	.596
SARC (219)	1.063	.336	SARC (214)	1.082	.240
SKCM (94)	1.118	.521	SKCM (94)	1.212	.317
STAD (406)	.944	.111	STAD (384)	.915	.065
TGCT (127)	1.647	.123	TGCT (127)	1.670	.129
THCA (503)	1.273	.226	THCA (497)	.255	.127
THYM (106)	1.180	.842	THYM (106)	2.488	.301
UCEC (178)	.915	.472	UCEC (176)	1.066	.657
UCS (54)	1.225	.106	UCS (52)	1.203	.164
UVM (33)	1.417	.082	UVM (33)	1.480	.054

^aNotes: hazard ratio.